July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Nancy Lee on Designing Pembrolizumab Trial for Head and Neck Cancer and FDA Approval
Jun 26, 2025, 07:39

Nancy Lee on Designing Pembrolizumab Trial for Head and Neck Cancer and FDA Approval

Memorial Sloan Kettering Cancer Center shared on X:

“The FDA has approved the immunotherapy drug pembrolizumab (Keytruda) to be given before and after surgery for patients with head and neck squamous cell cancer (HNSCC) in combination with standard therapy.
Dr. Nancy Lee, a radiologist oncologist at MSK, helped design the clinical trial showing that immunotherapy given around surgery could reduce recurrence of some head and neck cancers.
‘This is the first FDA approval in nearly two decades of a treatment for this patient group,’ she says. ‘It will be practice-changing and benefit many people.’

Learn more about Dr. Lee’s research.”